Bay 65-1942 2mg 2mg | Purity Not Available
Adooq Bioscience
Bay 65-1942 is an ATP-competitive inhibitor that selectively targets IKK?? kinase activity.
More Information Supplier PageBay 65-1942 is an ATP-competitive inhibitor that selectively targets IKK?? kinase activity.
More Information Supplier PageBay 65-1942 is an ATP-competitive inhibitor that selectively targets IKK?? kinase activity.
More Information Supplier PageBay 65-1942 is an ATP-competitive inhibitor that selectively targets IKK?? kinase activity.
More Information Supplier PageBay 65-1942 is an ATP-competitive inhibitor that selectively targets IKK?? kinase activity.
More Information Supplier PageBoceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
More Information Supplier PageBCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier Page